| [1] | Yannan LI, Changzheng LI. Gut microbiota in hepatitis B cirrhosis[J]. Journal of Clinical Hepatology, 2025, 41(3): 552-555. doi: 10.12449/JCH250324 |
| [2] | Haiyang ZANG, Weina LI, Shousheng LIU, Yong ZHOU, Yongning XIN. Predictive factors for functional cure after sequential therapy with nucleos(t)ide analogues and pegylated interferon alfa-2b in treatment of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2023, 39(2): 299-306. doi: 10.3969/j.issn.1001-5256.2023.02.008 |
| [3] | Ning TAN, Jianxiang LIU, Qian KANG, Jiali PAN, Yifan HAN, Hongyu CHEN, Xiaoyuan XU. Serum levels of soluble programmed death-1 and soluble programmed death-ligand 1 in chronic hepatitis B patients with clinical cure and their clinical features[J]. Journal of Clinical Hepatology, 2023, 39(1): 50-55. doi: 10.3969/j.issn.1001-5256.2023.01.008 |
| [4] | Jian ZHUANG, Weiwen ZHU, Chao ZHANG. Establishment and validation of a noninvasive diagnostic model for chronic hepatitis B liver fibrosis based on LASSO regression[J]. Journal of Clinical Hepatology, 2022, 38(8): 1790-1795. doi: 10.3969/j.issn.1001-5256.2022.08.014 |
| [5] | GUT｜FOXA2 prevents hyperbilirubinaemia in acute liver failure by maintaining apical MRP2 expression[J]. Journal of Clinical Hepatology, 2022, 38(7): 1619-1619. doi: 10.3969/j.issn.1001-5256.2022.07.gwjpwzjj2 |
| [6] | Yan HUANG, Qiongyue ZHANG, Erping LUO, Weifeng ZHAO, Jianhe GAN. Clinical cure of the non-dominant population in chronic hepatitis B patients with HBsAg>3000 IU/mL: A report of two cases[J]. Journal of Clinical Hepatology, 2022, 38(7): 1608-1611. doi: 10.3969/j.issn.1001-5256.2022.07.027 |
| [7] | Weili NIU, Yongsu WANG, Qingshan WU, Lin ZHANG, Zhongqin ZHANG, Xiaojun YANG, Xianbin ZHU, Wenqin XIAO, Mingping JI. A clinical study of clinical cure after the addition of interferon therapy in chronic hepatitis B patients with low-level HBsAg previously treated with nucleos(t)ide analogues[J]. Journal of Clinical Hepatology, 2021, 37(8): 1793-1797. doi: 10.3969/j.issn.1001-5256.2021.08.010 |
| [8] | Huang KuiYuan, Liu ZiYing, Zhang XiaoYong. Hepatitis B cured by the activation of intrahepatic innate immunity:Research advances and new strategies[J]. Journal of Clinical Hepatology, 2020, 36(5): 971-976. doi: 10.3969/j.issn.1001-5256.2020.05.003 |
| [9] | Shi Ke, Zhang Qun, Li YuXin, Wang XianBo. Research advances in the risk prediction models for chronic hepatitis B-related hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2020, 36(10): 2315-2319. doi: 10.3969/j.issn.1001-5256.2020.10.034 |
| [10] | Wu ShanShan, Kong YuanYuan. Methodology of establishing predictive models for clinical endpoints in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2020, 36(9): 1923-1927. doi: 10.3969/j.issn.1001-5256.2020.09.002 |
| [11] | Gao XiaoHong, Cheng Ni, Cao JiaoJiao. Clinical cure in patients with hepatitis B cirrhosis treated with pegylated interferon α-2b: A case report[J]. Journal of Clinical Hepatology, 2020, 36(6): 1347-1348. doi: 10.3969/j.issn.1001-5256.2020.06.031 |
| [13] | Chinese Society of Infectious Disease, Chinese Society of Hepatology, Chinese Medical Association. The expert consensus on clinical cure (functional cure) of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2019, 35(8): 1693-1701. doi: 10.3969/j.issn.1001-5256.2019.08.008 |
| [14] | Wang YaPing, Shi YuMing, Xu Min, Yang Zhan, Li Jing, Chen Keng, Liu HuiYuan. Successful treatment and clinical cure of acute-on-chronic liver failure in third trimester of pregnancy: A case report[J]. Journal of Clinical Hepatology, 2018, 34(7): 1523-1525. doi: 10.3969/j.issn.1001-5256.2018.07.032 |
| [15] | Wu Di, Huang Da, Ning Qin. New strategies for clinical cure and Institute of hepatitis B:viral suppression combined with immune modulation and its road map[J]. Journal of Clinical Hepatology, 2018, 34(5): 919-925. doi: 10.3969/j.issn.1001-5256.2018.05.002 |
| [16] | Wang WeiJing, Xie Qing. Challenges and strategies of antiviral therapy for chronic hepatitis B-how to achieve the maximization of clinical cure?[J]. Journal of Clinical Hepatology, 2017, 33(8): 1415-1418. doi: 10.3969/j.issn.1001-5256.2017.08.002 |
| [17] | Yin XueRu, Hou JinLin. Establishment of a clinical research collaborative network for clinical cure of hepatitis B and prevention of mother-to-child transmission[J]. Journal of Clinical Hepatology, 2017, 33(8): 1409-1414. doi: 10.3969/j.issn.1001-5256.2017.08.001 |
| [19] | Zhang ZeTian, Ji HuiFan, Chen Shuai, Li Xu, Yang WenXuan, Zhang GuoShan, Guo XiaoLin. Clinical cure of chronic hepatitis B: a case report[J]. Journal of Clinical Hepatology, 2016, 32(8): 1578-1579. doi: 10.3969/j.issn.1001-5256.2016.08.030 |
DownLoad: